PTPN22 and colitis: Strikingly, transgenic augmentation of PEST domain-enriched tyrosine phosphatase (Pep) to downregulate TCR signaling strength reversed exacerbated colitis and increased disease-free percentage of Blimp-1-deficient NOD mice.